Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II dose-ranging study of locally applied NRL001 in faecal incontinence
2011-003206-25Phase 2Completed
- Sponsor
- Norgine
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Methoxamine in fecal incontinence (FI) (4 arms), sponsored by Norgine. Started Jan 2012; status: completed.
02
Drugs
Methoxamine
03
Conditions
fecal incontinence (FI)
Beyond the preview
Go deeper on 2011-003206-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003206-25.